THG-213.29

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTHG-213.29
Drug Alias NameTHG-213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E2 inhibitors
TargetsProstaglandin E2
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheratechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheratechnologies Inc
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A